Financial Toxicity in Lung Cancer: An assessment of magnitude, perception, and impact on quality of life

Part of the Surgical Grand Rounds Series - Valerie Peterson, CRNP and Sarah Hazell, MD explain financial toxicity in lung cancer treatment and how it threatens quality of life and increases symptom burden. They also discuss how treatment related bankruptcy has been shown to be an independent risk factor for mortality.

Created by

Johns Hopkins Greater Washington Area